Gebelik ve Perikardiyal Hastalıklar
Abstract
Keywords
References
- 1. Pieper PG. Use of medication for cardiovascular disease during pregnancy. Nat Rev Cardiol 2015;12:718–29.
- 2. Haiat R, Halphen C. Silent pericardial effusion in late pregnancy: a new entity. Cardiovasc Intervent Radiol 1984;7:267–9.
- 3. Halphen C, Haiat R, Clément F, et al. Silent pericardial effusion in late pregnancy: echocardiographic detection in the third trimester of pregnancy. J Gynecol Obstet Biol Reprod 1982;11:245–8.
- 4. Vitse M, Lesbre JP, Boulanger JC et al. Our experience of the detection of latent pericardial effusions in the 3rd trimester of pregnancy. Rev Fr Gynecol Obstet 1984;79:765–9.
- 5. Imazio M, Brucato A, Rampello S, Armellino F, Trinchero R, Spodick DH, Adler Y. Management of pericardial diseases during pregnancy. J Cardiovasc Med (Hagerstown) 2010;11:557–562.
- 6. Ristić AD, Seferović PM, Ljubić A, et al. Pericardial disease in pregnancy. Herz 2003;28:209–15.
- 7. Forbat LN, Hancock BW, Gershlick AH. Methotrexateinduced peric arditis and pericardial effusion; first reported case. Postgrad Med J 1995;71:244–5.
- 8. Sharma S, Jagdev S, Coleman R et al. Serosal complications of single-agent low-dose methotrexate used in gestational trophoblastic diseases: first reported case of methotrexateinduced peritonitis Br J Cancer 1999;81:1037–41.
Details
Primary Language
Turkish
Subjects
Clinical Sciences
Journal Section
Review
Authors
Özgür Yılmaz
This is me
Türkiye
Tamer Altındağ
This is me
Türkiye
Burcu Artunç Ülkümen
This is me
Türkiye
Halil Gürsoy Pala
*
Türkiye
Publication Date
December 1, 2017
Submission Date
September 30, 2016
Acceptance Date
January 23, 2017
Published in Issue
Year 2017 Volume: 7 Number: 3